Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
| DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
|---|---|---|---|---|---|---|---|---|
| BLK proto-oncogene, Src family tyrosine kinase in Human [GtoPdb: 1940] [UniProtKB: P51451] | ||||||||
| GtoPdb | - | - | 6.82 | pIC50 | 150 | nM | IC50 | J Med Chem (2019) 62: 6561-6574 [PMID:31260299] |
| Bruton tyrosine kinase in Human [GtoPdb: 1948] [UniProtKB: Q06187] | ||||||||
| GtoPdb | - | - | 8.28 | pIC50 | 5.3 | nM | IC50 | J Med Chem (2019) 62: 6561-6574 [PMID:31260299] |
| FYN proto-oncogene, Src family tyrosine kinase in Human [GtoPdb: 2026] [UniProtKB: P06241] | ||||||||
| GtoPdb | - | - | 6.78 | pIC50 | 165.2 | nM | IC50 | J Med Chem (2019) 62: 6561-6574 [PMID:31260299] |
| IL2 inducible T cell kinase in Human [GtoPdb: 2046] [UniProtKB: Q08881] | ||||||||
| GtoPdb | - | - | 6.51 | pIC50 | 306.9 | nM | IC50 | J Med Chem (2019) 62: 6561-6574 [PMID:31260299] |
| SRC proto-oncogene, non-receptor tyrosine kinase in Human [GtoPdb: 2206] [UniProtKB: P12931] | ||||||||
| GtoPdb | - | - | 6.04 | pIC50 | 902.5 | nM | IC50 | J Med Chem (2019) 62: 6561-6574 [PMID:31260299] |
| tec protein tyrosine kinase in Human [GtoPdb: 2238] [UniProtKB: P42680] | ||||||||
| GtoPdb | - | - | 6.64 | pIC50 | 227 | nM | IC50 | J Med Chem (2019) 62: 6561-6574 [PMID:31260299] |
Our curators have not yet identified this ligand in ChEMBL, but you may find additional data by searching on the ChEMBL site using the ligand's name or structure.